The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma

Cancer

Volumn 101, Issue 5, 2004, Pages 963-968

  Shimazui, Toru ^a   Yoshikawa, Kazuhiro ^b   Uemura, Hirotsugu ^c   Hirao, Yoshihiko ^c   Saga, Shinsuke ^b   Akaza, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell adhesion molecule; Kidney; Metastasis; Polymerase chain reaction; Prognosis

Indexed keywords

CADHERIN; CADHERIN 6; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CANCER SURVIVAL; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECURRENT CANCER;

CADHERINS; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM CIRCULATING CELLS; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 4143060402     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20479     Document Type: Article

References (14)

1. Belldegrun A, Franklin JR, Figlin R. Commentary on prognostic factors in renal cell carcinoma. J Urol. 1995;154:1274.
2. Giroldi LA, Bringuier PP, Schalken JA. Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms. Invasion Metastasis. 1995;14:71-81.
3. Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA. Complex cadherin expression in renal cell carcinoma. Cancer Res. 1996;56:3234-3237.
4. Shimazui T, Oosterwijk E, Akaza H, et al. Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma. Clin Cancer Res. 1998;4:2419-2424.
5. Shimazui T, Yoshikawa K, Uemura H, et al. Detection of cadherin-6 mRNA by nested RT-PCR as a potential marker for circulating cancer cells in renal cell carcinoma. Int J Oncol. 2003;23:1049-1054.
6. Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A. 1998;95:4589-4594.
7. Beitsch PD, Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am J Surg. 2000;180:446-448.
8. Hardingham JE, Hewett PJ, Sage RE, et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer. 2000;89:8-13.
9. McIntyre IG, Spreckley K, Clarke RB, Anderson E, Clarke NW, George NJ. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells. Br J Cancer. 2000;83:992-997.
10. Uemura H, Nakagawa Y, Yoshida K, et al. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas. Br J Cancer. 1999;81:741-746.
11. McKiernan JM, Buttyan R, Bander NH, et al. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer. 1999;86:492-497.
12. Ashida S, Okuda H, Chikazawa M, et al. Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res. 2000;6:3817-3822.
13. Shimazui T, Akaza H. Current status of molecular markers in relation to metastasis and prognosis in renal cell carcinoma. Recent Res Dev Cancer. 2002;4:625-634.
14. de la Taille A, Cao Y, Sawczuk IS, et al. Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion. Cancer Detect Prev. 2000;24:579-588.